Last $37.31 USD
Change Today +0.47 / 1.28%
Volume 212.3K
CNMD On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 5:20 PM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

conmed corp (CNMD) Snapshot

Open
$36.89
Previous Close
$36.84
Day High
$37.49
Day Low
$36.62
52 Week High
05/19/14 - $50.47
52 Week Low
10/7/13 - $32.95
Market Cap
1.0B
Average Volume 10 Days
151.0K
EPS TTM
$1.76
Shares Outstanding
27.3M
EX-Date
09/11/14
P/E TM
21.2x
Dividend
$0.80
Dividend Yield
2.14%
Current Stock Chart for CONMED CORP (CNMD)

conmed corp (CNMD) Related Bloomberg News

View More Bloomberg News

conmed corp (CNMD) Related Businessweek News

No Related Businessweek News Found

conmed corp (CNMD) Details

CONMED Corporation provides surgical devices and equipment for minimally invasive procedures and monitoring. It offers sports medicine products, including powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, metal and bioabsorbable implants, and related disposable products and fluid management systems; powered surgical instruments for use in large and small bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, plastic, ENT, neurological, spinal, and cardiothoracic surgeries; electrosurgical generators and related instruments; and 2D and 3D video systems for use in minimally invasive orthopedic and general surgeries. The company also provides patient monitoring products comprising vital signs and cardiac monitoring products, including pulse oximetry equipment and sensors, ECG electrodes and cables, cardiac defibrillation and pacing pads, and blood pressure cuffs; surgical suction instruments and tubing products; and IV products used in critical care areas. In addition, it offers endomechanical instrumentation products, such as trocars, clip appliers, scissors, and surgical staplers used in the minimally invasive laparoscopic and gynecological surgery. Further, the company provides gastrointestinal and pulmonary products consisting of minimally invasive diagnostic and therapeutic products, including mucosal management devices, forceps, scope management accessories, bronchoscopy devices, dilatation, stricture management devices, hemostasis, biliary devices, and polypectomy. Its products are used by surgeons and physicians in orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. The company operates in the United States, Canada, the United Kingdom, Japan, Australia, and internationally. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.

3,600 Employees
Last Reported Date: 02/24/14
Founded in 1970

conmed corp (CNMD) Top Compensated Officers

Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $320.8K
Executive Vice President of Corporate Commerc...
Total Annual Compensation: $371.9K
Principal accounting Officer, Executive Vice ...
Total Annual Compensation: $316.9K
General Counsel and Executive Vice President ...
Total Annual Compensation: $290.6K
Compensation as of Fiscal Year 2013.

conmed corp (CNMD) Key Developments

CONMED Corporation Announces Quarterly Cash Dividend Payable on October 6, 2014

CONMED Corporation announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on October 6, 2014 to all shareholders of record as of September 15, 2014.

CONMED Corporation Reports Earnings Results for the Six Months Ended June 30, 2014

CONMED Corporation reported earnings results for the six months ended June 30, 2014. For the six months, the company reported net income of $18.88 million, or $0.68 per diluted share, compared to $20.02 million, or $0.71 per diluted share, for the same period ended June 30, 2013. Net sales were $370.09 million, compared to $380.01 million for the same period ended June 30, 2013.

CONMED Corporation Announces Earnings Results for the Second Quarter Ended June 30, 2014; Revises Earnings Guidance for the Full Year 2014

CONMED Corporation announced earnings results for the second quarter ended June 30, 2014. For the quarter, the company reported adjusted diluted earnings per share increased 9.3% to $0.47, compared with $0.43 in the prior-year. Sales were $188.2 million, a decrease of 2.5%, caused principally by weaker sales of general surgery devices, surgical visualization capital products and the discontinuance of the Cascade PRP product line. Diluted earnings per share on a GAAP basis came in at $0.37, an increase of 8.8% over the prior year period. Sales were $188.2 million, a year-over-year decline of 2.5% or 2.3% on a constant currency basis. This was comprised of a 2.3% decrease in single-use devices and the 3.1% decline in capital products compared to the second quarter last year on a reported basis. At the end of the quarter, the net debt-to-book capitalization calculation was 21.1%, an amount that will allow the company to continue to return cash to shareholders in the form of dividends and share repurchases, as well as seeking selective acquisitions. The company cut its earnings guidance for 2014. The company now expects 2014 sales of $735 million to $745 million, compared with its prior guidance of $770 million to $780 million, due to the first half sales results and its outlook for the remainder of the year. It lowered its forecast for adjusted earnings per share to $1.85 to $1.95, down from its prior guidance of $1.90 to $2.00. These reductions in sales and earnings are a result of an environment of lower health care procedure counts in the United States and new product introductions coming later in the year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CNMD:US $37.31 USD +0.47

CNMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ascom Holding AG SFr.13.35 CHF -0.05
Integra LifeSciences Holdings Corp $49.71 USD +0.07
Masimo Corp $24.02 USD +2.74
NuVasive Inc $34.46 USD -0.41
Orthofix International NV $30.38 USD -0.58
View Industry Companies
 

Industry Analysis

CNMD

Industry Average

Valuation CNMD Industry Range
Price/Earnings 29.5x
Price/Sales 1.3x
Price/Book 1.7x
Price/Cash Flow 29.0x
TEV/Sales 0.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CONMED CORP, please visit www.conmed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.